PD-1 blockade counteracts post-COVID-19 immune abnormalities and stimulates the anti-SARS-CoV-2 immune response – DocWire News

JCI Insight. 2021 Nov 16:e146701. doi: 10.1172/jci.insight.146701. Online ahead of print.
ABSTRACT
A substantial proportion of patients who have recovered from coronavirus disease-2019 (COVID-19) experience COVID-19-related symptoms, even months after hospital…

Click here to view the original article.